Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma
G Poli, Carmen Ruggiero, Giulia Cantini, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 5, pp. 1712-1724
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?
Hongliang Liu, Yu Zhang, Li Li, et al.
Molecular Therapy — Oncolytics (2021) Vol. 20, pp. 240-264
Open Access | Times Cited: 69
Targeting the cytoskeleton against metastatic dissemination
Carmen Ruggiero, Enzo Lalli
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 1, pp. 89-140
Open Access | Times Cited: 45
The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
Maja Mizdrak, Tina Tičinović Kurir, Joško Božić
Biomedicines (2021) Vol. 9, Iss. 2, pp. 174-174
Open Access | Times Cited: 34
FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance
Zhongxun Li, Jiao Shi, Nannan Zhang, et al.
Journal of Cancer (2022) Vol. 13, Iss. 8, pp. 2528-2539
Open Access | Times Cited: 26
The role of stromal cells in epithelial–mesenchymal plasticity and its therapeutic potential
Juanjing Wang, Junmei Peng, Yonglin Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma
Yue Chen, Tian Tian, Zhiyong Li, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 5
Open Access | Times Cited: 38
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland
Serena Martinelli, Giulia Cantini, Arianna Pia Propato, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
FSCN1 as a new druggable target in adrenocortical carcinoma
Carmen Ruggiero, Mariangela Tamburello, Elisa Rossini, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 1, pp. 210-223
Open Access | Times Cited: 10
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane
Giulia Cantini, Elena Niccolai, Letizia Canu, et al.
Endocrine Related Cancer (2023) Vol. 30, Iss. 10
Open Access | Times Cited: 10
Integrated multi-omics and experimental approaches identify fascin actin-bundling protein 1 as an unfavorable prognostic biomarker in adrenocortical carcinoma
Ping He, Yi‐Hao Chen, Ming Xi, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Bai Wen, Jun-Song Ren, Min Xia, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
Jiayu Liang, Zhihong Liu, Xin Wei, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 23
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model
Roberta Armignacco, Giulia Cantini, G Poli, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1931-1931
Open Access | Times Cited: 20
Management of adrenocortical carcinoma: are we making progress?
Barbara Kiesewetter, Philipp Riss, Christian Scheuba, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 18
The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women
Eman Reda Galal, Dina A. Abdelhakam, Lamiaa Khalaf Ahmed, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 2
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma
Fabiano Flauto, Maria Cristina De Martino, Chiara Vitiello, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4061-4061
Open Access | Times Cited: 2
The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
Peter M. van Koetsveld, Sara G Creemers, Fadime Dogan, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 105, Iss. 2, pp. 407-417
Open Access | Times Cited: 18
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
André Marquardt, Laura‐Sophie Landwehr, Cristina L. Ronchi, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4671-4671
Open Access | Times Cited: 16
Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study
Fuxun Zhang, Fan Zhang, Zhihong Liu, et al.
Advances in Therapy (2019) Vol. 36, Iss. 10, pp. 2756-2768
Closed Access | Times Cited: 17
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma
Jiayu Liang, Zhihong Liu, Tianjiao Pei, et al.
Disease Markers (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 16
Downregulation of fascin in the first trimester placental villi is associated with early recurrent miscarriage
Jones Lamptey, Fangfang Li, Enoch Appiah Adu‐Gyamfi, et al.
Experimental Cell Research (2021) Vol. 403, Iss. 1, pp. 112597-112597
Closed Access | Times Cited: 11
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
Mario Detomas, Claudia Pivonello, Bianca Pellegrini, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2234-2234
Open Access | Times Cited: 8
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment
L. Fei, Giulia Cantini, Alessio Nocentini, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 7, pp. 1449-1458
Open Access | Times Cited: 4
Targeted NGS Molecular Profiling and Its Clinical Application in Adrenocortical Cancer
Francesca Cioppi, Giulia Cantini, Tonino Ercolino, et al.
European Journal of Endocrinology (2024) Vol. 191, Iss. 1, pp. 17-30
Open Access | Times Cited: 1
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
Giulia Cantini, Laura Fei, Letizia Canu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top